New obesity drug tested in blood-level study – no cure expected
NCT ID NCT06642571
First seen Jan 10, 2026 · Last updated Apr 30, 2026 · Updated 16 times
Summary
This completed Phase 1 study tested two different forms of the experimental drug NNC0519-0130 in 46 adults with overweight or obesity. The main goal was to measure how much of each version gets into the blood, not to treat or cure obesity. Participants received both formulations by chance, and the study lasted about 24 weeks. No direct health benefit was intended.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.